Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Miami Beach, FL
SEC filing record 1 source field available
Fiscal year end
31 December
SAB Biotherapeutics, Inc. has filed 429 SEC EDGAR filings since 07 Dec 2020

SEC filing history

Showing 151-175 of 429 matching filings.

Per page
25
Current page
7
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
28 Nov 2023
Reporting date
24 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Nov 2023
Reporting date
24 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Nov 2023
Reporting date
24 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
22 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-275319

S-3/A

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A

Filing date
15 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
15 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39871

DEFA14A

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
14 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-275319

S-3

Filing date
03 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Nov 2023
Reporting date
30 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
03 Nov 2023
Reporting date
30 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39871

DEF 14A

Filing date
30 Oct 2023
Reporting date
30 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
24 Oct 2023
Reporting date
23 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Oct 2023
Reporting date
23 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39871

PRE 14A

Filing date
20 Oct 2023
Reporting date
20 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-494844

D filing

Filing date
16 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .